Envoy Medical, Inc. (COCH)
Nasdaq: COCH · Orthopedic, Prosthetic & Surgical Appliances & Supplies · White Bear Lake, MN · filing with the SEC since 2021
Who owns Envoy Medical, Inc.
As filed with the SECHolders of 5% or more
4
Glen A. Taylor holds 84.8% of Class A Common Stock, as its SCHEDULE 13D/A filed Feb 17, 2026 says.
Directors and officers
9
report now, of 18 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Glen A. Taylor
SCHEDULE 13D/A · filed Feb 17, 2026 · Class A Common Stock · 44.2% in Dec 8, 2025
Anzu SPAC GP I LLC
SCHEDULE 13D · filed Dec 26, 2024 · Class A common stock, par value $0.0001 per share
Nantahala Capital Management, LLC
SCHEDULE 13G · filed May 15, 2026 · Class A Common Stock, par value $0.0001 per share
Bleichroeder LP
SCHEDULE 13G · filed May 14, 2026 · Class A Common Shares
Aristeia Capital, L.L.C.
SCHEDULE 13G/A · filed May 15, 2025 · Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share · reported falling below 5%
Ayrton Capital LLC
SCHEDULE 13G/A · filed May 11, 2026 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%, from 7.87% in Feb 11, 2026
Walleye Capital LLC
SCHEDULE 13G/A · filed Feb 6, 2025 · Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share · reported falling below 5%
Alta Partners LLC
SCHEDULE 13G/A · filed Sep 14, 2026 · Class A Common Stock · reported falling below 5%, from 8.3% in Aug 21, 2025
What COCH reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 31, 2025.
Insider tradesForm 4
0sales
6purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$8.2Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lucas Brent T. | Chief Executive Officer | 0 | $0 | 0 | 1 | $0 |
| Potashnick Robert | CAO & VP of Finance | 0 | $0 | 0 | 1 | $100,000 |
| Brynelsen Charles | director | 0 | $0 | 0 | 1 | $400,000 |
| Kantor Susan | director | 0 | $0 | 0 | 1 | $0 |
| Patel Mona Chetan | director | 0 | $0 | 0 | 1 | $100,000 |
| Taylor Glen A | director | 0 | $0 | 0 | 1 | $7.5M |